DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV1-45; IGHV3-21; IGHV5-51; IGHV3-20; IGHV3-35; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	95	161	59.0062111801242	0	0	0	0	0	0	0
up	LYZL6; HP; S100A8; S100A9; ELANE; IL10; S100A12; IRF8; CEBPE; DEFB108B; TLR9; STAB1; SLAMF8; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHV1-45; IGHA2; IGLC2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-35; IGHV3-23; IGHV1-69; HAMP; IGHV1-69-2; IGHV4-31; IGLC7; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	68	216	31.4814814814815	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; GYPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; GYPB; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD48; IGLC6; IGLC2; IGLC3; IGHV1-2; CEACAM8; CEACAM3; IGLV3-21; FOXJ1; SIRPG; CD84;	GO:0050900~leukocyte migration	68	193	35.2331606217617	0	0	0	0	0	0	0
down	COL6A5; ISLR; NCAN; ADAM12; TGFB1I1; NRP2; MPDZ; CNTN5; ITGBL1; HAPLN1; LAMC1; COL6A1; COL6A2; COL6A3; CCL2; CDH2; VCAM1; COL5A1; TNXB; NME2; ANOS1; LAMA2; TNC; AZGP1; COL8A1; THBS2; SPAM1; COL15A1; CXCL12; CCL11; APLP1; MFAP4; CDH11; CDH15; LGALS4; CNTNAP1; SRPX; COL16A1; DPT; MFGE8; FAP; PTK7; LSAMP; TPBG; NID2; OPCML; HEPACAM; POSTN; CDSN; IGFBP7; LAMA4; DDR2; SVEP1; FLG2; CERCAM; AMTN; CGREF1; COL12A1; ADAM2; OMD; MXRA8; HAPLN2; ITGA11; CNTN6; LOXL2; EMILIN1; PCDHA3; CDH16; PCDHA7; PCDHGA2; PCDHAC2; PCDHA11; PCDHB5; SPON2; PARD3B; PCDHA9; PCDHB10; PCDHGB4; PCDH18; PCDHA4; PCDHGA4; PCDHA2; PCDHGC4; GPNMB; PCDHGA11; PCDHGB7; PCDHGA12;	GO:0007155~cell adhesion	87	454	19.1629955947137	0	0	0	0	0	0	0
down	TNFRSF11B; NCAN; MATN3; ADAM12; COL1A1; COL3A1; COL4A1; FGG; COL5A2; DCN; COL1A2; COL4A2; FGF2; HAPLN1; LAMC1; COL11A1; COL6A1; COL6A2; COL6A3; NID1; ELN; PDGFRA; VCAM1; COL5A1; BGN; FBLN1; LAMA2; TNC; COL8A1; LOX; FBN1; COMP; LUM; ITGA8; MFAP2; LAMB2; ADAMTS20; FBLN2; HSPG2; COL14A1; COL16A1; LOXL1; FOXF1; FOXF2; DMP1; MFAP5; NID2; LAMA4; DDR2; EGFLAM; CCDC80; ABI3BP; ADAMTSL2; PXDN; KAZALD1; DSPP; FBLN5; ITGA11; LAMC3; MMP2; COL15A1; MMP23B; MMP12; ECM2; MMP7; MMP3; POSTN; RECK;	GO:0030198~extracellular matrix organization	68	230	29.5652173913043	0	0	0	0	0	0	0
down	DCLK1; DCX; POU3F3; NES; DRP2; ASIC2; DMBX1; SHC3; ADGRA2; NDN; TIMP4; ARNT2; ROBO2; IL1RAPL2; CNTN6; TBX2; NCAN; ZIC4; HAPLN1; EMX2; HAPLN2; ZIC1;	GO:0007417~central nervous system development	22	133	16.5413533834586	0.00011412707806735	0.00938219687612005	0.444981477384597	0.450345450053762	0.419875540940762	0.444981477384597	0.0831056240215033
down	TNFRSF11B; PLPP1; CXCL11; GREM1; GFRA3; REM1; FGF18; CXCL14; GNA14; C3; PENK; CXCL10; IGF1; INHA; FGF1; PGR; S100A6; FGF2; PDGFRB; GIP; CGB7; NR2F1; GNAT1; CCL2; OGN; NTF3; FGF7; IGFBP4; NR2F2; IGFBP6; IGFBP5; CNTFR; ADORA1; ADRA1A; FBN1; COL15A1; GDNF; ADCY8; NBL1; GRIA1; CXCL12; CCL11; STC1; GEM; CNTNAP1; CCL8; CCL7; ROR2; CXCL9; PTK7; OR2F1; PRKG1; PDE1C; GPNMB; PRKD1; RPS6KA2; CNGA3; DDR2; PLCXD3; SYDE1; RASSF8; IL17D; CASKIN1; FGF14; TRIM63; DIRAS2; DLC1; RASL10B; CCL13; TRIM54; PDE11A; FGF20; CYTL1; GPR173; FGF21; ARHGAP20; ARHGAP28; PPP1R1B; OR52A1; TRHDE; CLEC11A; SCUBE1; GABRA6; GABRR3; GABRA2; GABRG3; GLRB; PLPP3; NPR2; GABRB2; PLPPR5; NPR1; CHRNA1; GABRA1;	GO:0007165~signal transduction	94	989	9.50455005055612	0.00011972819677652	0.00944894928960336	0.466580782838118	0.472447464480168	0.434913116298163	0.466580782838118	0.0836969035534424
down	EFEMP2; TNXB; LOX; MFAP4; FBLN5; EMILIN1;	GO:0048251~elastic fiber assembly	6	9	66.6666666666667	0.00012923642667739	0.00980705653209599	0.503375881908444	0.509966939668991	0.459823206118163	0.503375881908444	0.0868689459063072
down	ACTA2; ACTG2; ACTC1; ACTA1; FOXF1;	GO:0090131~mesenchyme migration	5	5	100	0.00013710855800752	0.010208120186749	0.533900724881306	0.541030369897697	0.47768621609822	0.533900724881306	0.0904214875692432
down	GFRA3; EDNRB; PMP22; ASIC2; BDNF; NTF3; NGF; NTF4; GDNF;	GO:0007422~peripheral nervous system development	9	27	33.3333333333333	0.00018231228665843	0.012621127774635	0.709377107387978	0.719404283154192	0.564985776354496	0.70919479510132	0.111795426318098
down	HOXC11; GREM1; GLI2; GLI3; HOXA11; EN1; DLX2; HOXC10; HOXC9;	GO:0009954~proximal/distal pattern formation	9	27	33.3333333333333	0.00018231228665843	0.012621127774635	0.709377107387978	0.719404283154192	0.564985776354496	0.70919479510132	0.111795426318098
down	COL3A1; RBP4; APELA; GLI2; GLI3; WT1; LOX; FBN1; HAND2; ISL1; IRX4; FOXF1; FOXL1; CACNA1C; NFATC4; ARMC4; SMYD1; OSR1; TBX5; FOXC2; STRA6; BICC1; SALL1; HSPB7; ZFPM2; PDLIM3; POPDC3;	GO:0007507~heart development	27	190	14.2105263157895	0.00020016802022448	0.0136183277207903	0.778453430653039	0.789863007805835	0.594499020066733	0.778453430653039	0.120628424057718
down	HSPB6; ADAM12; GREM1; FGF18; DDAH1; C3; FGF1; FGF2; APELA; C6; CMA1; AQP1; CCL11; ISL1; PRKD1; TWIST1; PTGIS; CCBE1; GATA6; ANGPTL4; VEGFD;	GO:0045766~positive regulation of angiogenesis	21	131	16.030534351145	0.00023607064828967	0.0152216606077118	0.917370539253684	0.931534778151065	0.642400525395916	0.917370539253684	0.134830426194442
down	TCF21; LIF; FOXF1; STRA6; ERRFI1;	GO:0060426~lung vasculature development	5	6	83.3333333333333	0.00023916445962446	0.0152216606077118	0.929153925641041	0.943742957678133	0.646304294850498	0.929153925641041	0.134830426194442
down	FGF10; NRP2; SRPX2; FGF18; HRG; THY1; FGF1; MMP2; COL4A2; APELA; FGFR1; CCL2; SCG2; COL8A1; COL15A1; MEOX2; PROK1; HAND2; HSPG2; MFGE8; FAP; PRKD1; CSPG4; HOXB13; ANGPTL4; FZD8; TMEM100; HIF3A; VEGFD; TBX4;	GO:0001525~angiogenesis	30	230	13.0434782608696	0.00034682782018524	0.0209688882163419	1	1	0.757649545546765	0.999999835438707	0.185738219232178
down	PITX3; CLDN1; ASS1; AGT; PENK; KRT14; CYP1A1; DCN; COL4A2; MMP7; PDGFRB; EDNRB; IGFBP5; TACR3; ADRA1A; SERPINF1; NPY2R; FOXG1; KRT83; SLC6A3; LRP1; RGN; KRT25; LOXL2;	GO:0007568~aging	24	166	14.4578313253012	0.00035072139439396	0.0209688882163419	1	1	0.761065425834894	0.999999835438707	0.185738219232178
down	GREM1; BMP4; GDNF; SIX2; SALL1;	GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis	5	7	71.4285714285714	0.00039012581738895	0.0229146855613132	1	1	0.793625393007381	0.999999835438707	0.20297370306484
down	VEGFD; GREM1; CRLF1; FGF18; GLP2R; SLC25A27; CGA; VIP; IGF2; KRT6A; CXCL10; IGF1; FGF1; FGF2; WNT2; PDGFRB; FGFR1; FGF5; BMP4; LIF; PDGFRA; EPCAM; POU3F3; NTF3; IL11; FGF7; BMP5; FGFR4; EDNRB; TNC; CNTFR; GDNF; THPO; PTGFR; ID4; ISL1; BNC1; GHRHR; TBX2; CTF1; SCX; MYOCD; OSR2; TSLP; OSMR; ARNT2; CD248; FGF20; FGF21; HOXC10; CLEC11A; PROK1;	GO:0008284~positive regulation of cell population proliferation	52	490	10.6122448979592	0.00040068760864941	0.0229146855613132	1	1	0.801978972548187	0.999999835438707	0.20297370306484
down	KERA; OGN; LUM; PRELP; FMOD; OMD;	GO:0042340~keratan sulfate catabolic process	6	12	50	0.000411352793793	0.0229384825677573	1	1	0.810365003772224	0.999999835438707	0.203184492189871
down	FGF10; TCF21; GLI3; PDGFRA; FOXF1; RBPMS2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	7	18	38.8888888888889	0.0004511713537294	0.0243283492537366	1	1	0.840532231997885	0.999999835438707	0.215495653399779
down	ODAM; MUSK; ALOX12B; AGR2; NGF; CRP; IGF1; HPN; BMP4; WT1; POU3F3; DRD1; FGFR4; TNC; MT3; CALCR; PTGFR; GCGR; HAND2; ACTA2; ACTG2; ACTC1; ACTA1; ANK2; LRRC32; ANGPT1; TWIST1; FOXD1; TMEM119; SFRP4; RBMS3; SLC26A9; SCX; RIMS1; OSR2; CTCFL; OSR1; SEC16B; ADAM2; C1QTNF1; EPB41L4B; EMILIN1;	GO:0010628~positive regulation of gene expression	42	374	11.2299465240642	0.00049736750150131	0.0248431919104326	1	1	0.867931039094902	0.999999835438707	0.220056026713465
down	SEMA3E; ANGPT1; CCBE1; ADGRA2; RSPO3; PARVA; LOXL2; VEGFD; RECK;	GO:0002040~sprouting angiogenesis	9	32	28.125	0.00051998116759188	0.0256480710914699	1	1	0.881397843721075	0.999999835438707	0.227185485568914
down	FGF18; GLI3; HOXA11; GDF5; PKDCC; GDF6; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	7	19	36.8421052631579	0.00058622864118462	0.027870580941139	1	1	0.913930451606834	0.999999835438707	0.246872033441386
down	PDGFRB; WT1; SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	5	8	62.5	0.00060327793720405	0.0283396992881807	1	1	0.92060213217338	0.999999835438707	0.251027389962423
down	COL11A1; COL5A1; COMP; SCX;	GO:0035989~tendon development	4	4	100	0.00068769260099355	0.0315538953897738	1	1	0.953829637578054	0.999999835438707	0.27949809637344
down	FXYD1; KCNK3; GRID2; ATP10A; S100A6; ATP6V1B1; GRIA1; SCNN1G; CLCNKB; GRIK2; GRIK3; FXYD3; GRIK4; ASIC2; ATP2B3; ANO4; NALCN; GJD3; ANO3; CHRNA1; GABRG3; GABRA2; GABRA1; GABRA6; GLRB; GABRB2; GABRR3;	GO:0034220~ion transmembrane transport	27	208	12.9807692307692	0.00070988886198653	0.0321979476942396	1	1	0.962550012634972	0.999999835438707	0.285202982912471
down	GREM1; GLI2; BMP4; GDF5; ADAMTS12; EFEMP1; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	7	20	35	0.00075150183662575	0.0333193960373622	1	1	0.978797665892107	0.999999835438707	0.295136548109797
down	FGFR1; MSX1; PRRX1; SIX1; OSR2; OSR1; SIX2;	GO:0042474~middle ear morphogenesis	7	20	35	0.00075150183662575	0.0333193960373622	1	1	0.978797665892107	0.999999835438707	0.295136548109797
down	GABRR3; GABBR2; BDNF; GABRA2; GABRB2; GABRA6; GABRG3; GABRA1;	GO:0007214~gamma-aminobutyric acid signaling pathway	8	27	29.6296296296296	0.00079349851418708	0.0347905015220249	1	1	0.994741355795624	0.999999835438707	0.308167306355291
down	FBN1; ALDH1A3; MFAP2; FOXL2; EFEMP1;	GO:0048048~embryonic eye morphogenesis	5	9	55.5555555555556	0.00089309415342131	0.0383059731456577	1	1	0.999999835438707	0.999999835438707	0.339306651102521
down	ODAM; FGF10; FZD7; CLDN1; MMP12;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	5	9	55.5555555555556	0.00089309415342131	0.0383059731456577	1	1	0.999999835438707	0.999999835438707	0.339306651102521
down	FSTL3; PDGFRB; PDGFRA; WT1; NR0B1; STRA6; SALL1;	GO:0030325~adrenal gland development	7	21	33.3333333333333	0.00095152833012168	0.0402127784430968	1	1	0.999999835438707	0.999999835438707	0.356196751174341
down	SMAD6; SLIT3; SLIT2; BMP4; ELN; TWIST1; ROBO2; EMILIN1;	GO:0003180~aortic valve morphogenesis	8	28	28.5714285714286	0.00096812315055605	0.0402127784430968	1	1	0.999999835438707	0.999999835438707	0.356196751174341
down	NRP2; CTSV; BDNF; NGF; NTF4; NTF3;	GO:0021675~nerve development	6	15	40	0.00103244696320848	0.0415717930287822	1	1	0.999999835438707	0.999999835438707	0.368234630648516
down	DRD2; HTR1B; ADORA1; NPY2R; GRIK2; GRIK3;	GO:0051967~negative regulation of synaptic transmission, glutamatergic	6	15	40	0.00103244696320848	0.0415717930287822	1	1	0.999999835438707	0.999999835438707	0.368234630648516
down	FABP7; GRID2; DRD2; DRD1; BACE1; SLC6A3;	GO:0060134~prepulse inhibition	6	15	40	0.00103244696320848	0.0415717930287822	1	1	0.999999835438707	0.999999835438707	0.368234630648516
down	CHRNA1; DRD1; KCNA1; GRIK2; KCND2; CACNA1H; SCN10A; SCN7A;	GO:0019228~neuronal action potential	8	29	27.5862068965517	0.00117218133994923	0.0453473290925457	1	1	0.999999835438707	0.999999835438707	0.401677574208288
down	LRRTM1; CBLN2; SLITRK1; SLITRK2; IL1RAPL2; LRRC4B; GPC6; LRFN5;	GO:1905606~regulation of presynapse assembly	8	29	27.5862068965517	0.00117218133994923	0.0453473290925457	1	1	0.999999835438707	0.999999835438707	0.401677574208288
down	DRGX; MATN2; NRP2; GFRA3; SLIT3; SLIT2; LGI1; GLI2; GLI3; ANOS1; BDNF; LAMA2; GDNF; CXCL12; GBX2; EPHA5; LAMB2; GFRA1; FOXD1; ENAH; SHC3; ROBO2; VSTM2L; CNTN6; UNC5C; UNC5D;	GO:0007411~axon guidance	26	206	12.621359223301	0.00126668469139091	0.0479165792786929	1	1	0.999999835438707	0.999999835438707	0.424435478652885
down	HOXC11; BMP4; HOXA11; OSR2; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	5	10	50	0.00127502301679239	0.0479165792786929	1	1	0.999999835438707	0.999999835438707	0.424435478652885
down	LRCOL1; CAPN8; CAPN9; ALPI; CTRB1; SST; CTRB2; CYP39A1;	GO:0007586~digestion	8	30	26.6666666666667	0.00140908844672549	0.0524553114224415	1	1	0.999999835438707	0.999999835438707	0.464638660493241
down	TPM2; TPM1; MYH8; DES; ACTC1; ACTA1; ACTN3; MYH2; MYH4;	GO:0030049~muscle filament sliding	9	38	23.6842105263158	0.00147166728057602	0.0532770558637886	1	1	0.999999835438707	0.999999835438707	0.471917508452419
down	FGF10; FGF18; F10; IGF2; FGF1; F7; FGF2; PDGFRB; FGFR1; FGF5; PDGFRA; FGF7; FGFR4; IGFBP5; CALCR; THPO; ANGPT1; MEIS3; MYOC; C1QTNF1; FGF20; NOX4;	GO:0051897~positive regulation of protein kinase B signaling	22	165	13.3333333333333	0.0015517780994635	0.0556665125498451	1	1	0.999999835438707	0.999999835438707	0.493082838021712
down	APOE; NPR1; NPR2; EDNRB; AQP1; PRKG1; NPPB;	GO:0019934~cGMP-mediated signaling	7	24	29.1666666666667	0.0018102731908195	0.064354396495259	1	1	0.999999835438707	0.999999835438707	0.570038376926222
down	FGF18; COL1A1; MMP2; CTSK;	GO:0001957~intramembranous ossification	4	6	66.6666666666667	0.00187559574356966	0.0653599320998146	1	1	0.999999835438707	0.999999835438707	0.578945210261294
down	BMP4; PDGFRA; PRRX1; DLX2; SIX1; TWIST1; SIX2; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	8	32	25	0.00199607128689117	0.0667603605959837	1	1	0.999999835438707	0.999999835438707	0.5913499258741
down	ACR; ADRB3; DRD1; LHCGR; CALCR; ADCY8; GHRHR; ADCY2; LGR5;	GO:0007190~activation of adenylate cyclase activity	9	40	22.5	0.00199638179177042	0.0667603605959837	1	1	0.999999835438707	0.999999835438707	0.5913499258741
down	RBP4; BMP5; TBX2; SGCG; SGCZ; SGCD;	GO:0048738~cardiac muscle tissue development	6	18	33.3333333333333	0.00220018682057499	0.0711870976553128	1	1	0.999999835438707	0.999999835438707	0.630561077649333
down	UCHL1; LOX; COMP; FLNC; WFIKKN2; NRAP;	GO:0048747~muscle fiber development	6	18	33.3333333333333	0.00220018682057499	0.0711870976553128	1	1	0.999999835438707	0.999999835438707	0.630561077649333
down	LGI1; GRIK2; KISS1; RIMS1; CLSTN2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	6	18	33.3333333333333	0.00220018682057499	0.0711870976553128	1	1	0.999999835438707	0.999999835438707	0.630561077649333
down	FGF2; WNT2; FGFR1; TBX2; ZFPM2; GATA6; TBX5;	GO:0060045~positive regulation of cardiac muscle cell proliferation	7	25	28	0.00220091888341312	0.0711870976553128	1	1	0.999999835438707	0.999999835438707	0.630561077649333
down	APOE; DRD2; NTF4; ADCY8; GRIA1; NFATC4; NPAS4; SHANK1;	GO:0007616~long-term memory	8	33	24.2424242424242	0.0023539113157004	0.0739660689813545	1	1	0.999999835438707	0.999999835438707	0.655176650018783
down	COL1A2; BMP4; AQP1; TWIST1; OSR2; OSR1; PITX2; TUFT1;	GO:0042476~odontogenesis	8	33	24.2424242424242	0.0023539113157004	0.0739660689813545	1	1	0.999999835438707	0.999999835438707	0.655176650018783
down	FGG; SERPINE2; PRKG1; ADAMTS18; C1QTNF1;	GO:0090331~negative regulation of platelet aggregation	5	12	41.6666666666667	0.00238056025358135	0.0739660689813545	1	1	0.999999835438707	0.999999835438707	0.655176650018783
down	GABRA1; GABRA2; GABRB2; NPAS4; NLGN2;	GO:1904862~inhibitory synapse assembly	5	12	41.6666666666667	0.00238056025358135	0.0739660689813545	1	1	0.999999835438707	0.999999835438707	0.655176650018783
down	CHRNA1; UCHL1; COMP; KCNA1; STRA6; HOXC10;	GO:0050905~neuromuscular process	6	19	31.5789473684211	0.00275250749431288	0.0803697070542434	1	1	0.999999835438707	0.999999835438707	0.711898795704066
down	SCX; TCF24; TCF21; TWIST2; HAND2; TWIST1; COLEC10; HMGB4;	GO:0032502~developmental process	8	34	23.5294117647059	0.00276010743356725	0.0803697070542434	1	1	0.999999835438707	0.999999835438707	0.711898795704066
down	SCT; AQP1; SCTR; AQP4;	GO:0009992~cellular water homeostasis	4	7	57.1428571428571	0.0028106993343856	0.0803697070542434	1	1	0.999999835438707	0.999999835438707	0.711898795704066
down	NPY2R; CA9; RIMS1; FBLN5;	GO:0046903~secretion	4	7	57.1428571428571	0.0028106993343856	0.0803697070542434	1	1	0.999999835438707	0.999999835438707	0.711898795704066
down	TCF21; CTSV; NR0B1; SCX;	GO:0060008~Sertoli cell differentiation	4	7	57.1428571428571	0.0028106993343856	0.0803697070542434	1	1	0.999999835438707	0.999999835438707	0.711898795704066
down	ADAMTS2; MMP2; MMP3; MMP7; COL15A1; MMP12; CTSK; ADAMTS14; MMP23B;	GO:0030574~collagen catabolic process	9	43	20.9302325581395	0.00305215490200195	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	C3; C9; C8B; C7; CFHR5;	GO:0006957~complement activation, alternative pathway	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	FGF2; PDGFRB; FGFR1; PDGFRA; NTF3;	GO:0010863~positive regulation of phospholipase C activity	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	SLIT2; IGFBP3; IGFBP5; LRP1; SEMA6D;	GO:0014912~negative regulation of smooth muscle cell migration	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	CCL2; AQP1; TNS2; MUC17; ABCA12;	GO:0019725~cellular homeostasis	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	IGF1; IGFBP3; IGFBP4; IGFBP5; GHRHR;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	FGF10; FOXF1; NFATC4; MYOCD; GATA6;	GO:0051145~smooth muscle cell differentiation	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	GABRA1; GABRB2; GABRG3; GABRA6; GABRA2;	GO:0051932~synaptic transmission, GABAergic	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	COL3A1; COL5A1; MFAP4; MFAP5; LTBP2;	GO:0097435~supramolecular fiber organization	5	13	38.4615384615385	0.00313794773814258	0.0842336175150381	1	1	0.999999835438707	0.999999835438707	0.746124542002875
down	FGF10; GLI2; BMP4; MSX1; NR0B1; ISL1; SALL1;	GO:0021983~pituitary gland development	7	27	25.9259259259259	0.00317420052055917	0.0846310490143681	1	1	0.999999835438707	0.999999835438707	0.749644910760184
down	FGF5; PDGFRA; EPCAM; MSX1; MSX2; MESP1;	GO:0023019~signal transduction involved in regulation of gene expression	6	20	30	0.00340239115021301	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	SCG2; CCL11; CCL7; CCL13; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	6	20	30	0.00340239115021301	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	CLEC3B; COL1A2; LOX; COMP; ROR2; GPNMB; PKDCC; ASPN; TUFT1;	GO:0030282~bone mineralization	9	44	20.4545454545455	0.0034879844174226	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	BMP4; SCX; TNMD;	GO:0035990~tendon cell differentiation	3	3	100	0.00354316892442808	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	BMP4; SCX; PITX2;	GO:0035993~deltoid tuberosity development	3	3	100	0.00354316892442808	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	FBN1; MFAP2; EFEMP1;	GO:0048050~post-embryonic eye morphogenesis	3	3	100	0.00354316892442808	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	SERPINE2; ASIC2; PIEZO2;	GO:0050974~detection of mechanical stimulus involved in sensory perception	3	3	100	0.00354316892442808	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	SLIT3; SLIT2; ROBO2;	GO:0061364~apoptotic process involved in luteolysis	3	3	100	0.00354316892442808	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	TCF21; PDGFRB; PDGFRA;	GO:0072277~metanephric glomerular capillary formation	3	3	100	0.00354316892442808	0.0884895226316024	1	1	0.999999835438707	0.999999835438707	0.783822498585795
down	ADRB3; DRD1; DRD2; ADRA1B; ADRA1A; SHANK1; ADRA2C;	GO:0007610~behavior	7	28	25	0.00376937602224059	0.0923848309550395	1	1	0.999999835438707	0.999999835438707	0.818326360874098
down	FGF10; GLI2; FST; FGF7; IGFBP5; KRT17; KRT25;	GO:0031069~hair follicle morphogenesis	7	28	25	0.00376937602224059	0.0923848309550395	1	1	0.999999835438707	0.999999835438707	0.818326360874098
down	COL3A1; CYP1A1; CLDN18; FOXF1; FAT4; MYOCD; CLMP;	GO:0048565~digestive tract development	7	28	25	0.00376937602224059	0.0923848309550395	1	1	0.999999835438707	0.999999835438707	0.818326360874098
down	SULT1C2; INMT; CYP1A1; VCAM1;	GO:0009308~amine metabolic process	4	8	50	0.00402098609288071	0.0952342390075034	1	1	0.999999835438707	0.999999835438707	0.843565847682846
down	IGFBP4; IGFBP3; IGFBP6; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	4	8	50	0.00402098609288071	0.0952342390075034	1	1	0.999999835438707	0.999999835438707	0.843565847682846
down	ABCC9; CACNA1H; ABCC8; KCNJ8;	GO:0098662~inorganic cation transmembrane transport	4	8	50	0.00402098609288071	0.0952342390075034	1	1	0.999999835438707	0.999999835438707	0.843565847682846
down	AGT; DRD2; NPR1; NPPB; EDNRB;	GO:0035815~positive regulation of renal sodium excretion	5	14	35.7142857142857	0.00405457479808935	0.0952342390075034	1	1	0.999999835438707	0.999999835438707	0.843565847682846
down	FGF10; VEGFD; SCG2; NTF3; CXCL12;	GO:0050930~induction of positive chemotaxis	5	14	35.7142857142857	0.00405457479808935	0.0952342390075034	1	1	0.999999835438707	0.999999835438707	0.843565847682846
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.00407223537120149	0.46301316170561	1	1	1	1	1
down	CLDN11; CLDN14; CLDN1; CLDN6; CLDN18; CLDN2;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	6	21	28.5714285714286	0.00415978809690065	0.0954332780835463	1	1	0.999999835438707	0.999999835438707	0.84532889602191
down	FZD4; FZD7; FRZB; SFRP4; FZD8; FZD10;	GO:0035567~non-canonical Wnt signaling pathway	6	21	28.5714285714286	0.00415978809690065	0.0954332780835463	1	1	0.999999835438707	0.999999835438707	0.84532889602191
down	BMP4; MYOCD; GATA6; TBX5; MESP1; NOX4;	GO:0055007~cardiac muscle cell differentiation	6	21	28.5714285714286	0.00415978809690065	0.0954332780835463	1	1	0.999999835438707	0.999999835438707	0.84532889602191
down	ADRA1A; DRD1; ADRA2C; ADRA1B; DRD2; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	6	21	28.5714285714286	0.00415978809690065	0.0954332780835463	1	1	0.999999835438707	0.999999835438707	0.84532889602191
down	GLI2; FGFR1; BMP4; SCX; OSR2; OSR1; SIX2; CYTL1;	GO:0002062~chondrocyte differentiation	8	37	21.6216216216216	0.00431235133154584	0.0983614933773403	1	1	0.999999835438707	0.999999835438707	0.871266441617382
down	GALR3; GAL; BDNF; NPW; STRA6; HCRTR2; CCKAR;	GO:0007631~feeding behavior	7	29	24.1379310344828	0.00444554050844381	0.0996710388995414	1	1	0.999999835438707	0.999999835438707	0.882866134018219
down	CXCL11; CXCL10; THY1; DRD1; BDKRB1; CXCL9; CEMIP;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	7	29	24.1379310344828	0.00444554050844381	0.0996710388995414	1	1	0.999999835438707	0.999999835438707	0.882866134018219
down	ADRA2C; EDNRB; ADORA1; NPY2R; GRM1; TMEM100; VIP;	GO:0051930~regulation of sensory perception of pain	7	29	24.1379310344828	0.00444554050844381	0.0996710388995414	1	1	0.999999835438707	0.999999835438707	0.882866134018219
down	MYF6; ROR2; FOXF1; RIPPLY2; FOXC2; HES7; MESP2; TBX18; MESP1;	GO:0001756~somitogenesis	9	46	19.5652173913043	0.00450513484313297	0.100436508988716	1	1	0.999999835438707	0.999999835438707	0.88964651501753
down	SLIT2; APOE; DCN; NR2F2; SERPINF1; STC1;	GO:0010596~negative regulation of endothelial cell migration	6	22	27.2727272727273	0.00503476803331437	0.110373303663658	1	1	0.999999835438707	0.999999835438707	0.977664655452903
down	PITX3; GLI2; LIF; EN2; EPHA5; EN1; DPYSL3; CTF1; ISL2;	GO:0048666~neuron development	9	47	19.1489361702128	0.00509331664463264	0.110391183435433	1	1	0.999999835438707	0.999999835438707	0.977823030896339
down	KCNK3; ABCC9; CACNA2D1; CACNG7; CACNA1S; CACNA1C; KCNK15; KCNIP1; KCND2;	GO:0061337~cardiac conduction	9	47	19.1489361702128	0.00509331664463264	0.110391183435433	1	1	0.999999835438707	0.999999835438707	0.977823030896339
down	SMAD6; SLIT2; BMP4; STRA6; ROBO2;	GO:0003184~pulmonary valve morphogenesis	5	15	33.3333333333333	0.00514748549217425	0.110391183435433	1	1	0.999999835438707	0.999999835438707	0.977823030896339
down	DRD1; MT3; LAMB2; ROR2; LAMC3;	GO:0014002~astrocyte development	5	15	33.3333333333333	0.00514748549217425	0.110391183435433	1	1	0.999999835438707	0.999999835438707	0.977823030896339
down	SLC22A2; VIP; NPR1; NPPB;	GO:0007589~body fluid secretion	4	9	44.4444444444444	0.00553996749543528	0.115056377563093	1	1	0.999999835438707	0.999999835438707	1
down	AGT; APOE; APOC1; AGTR1;	GO:0010873~positive regulation of cholesterol esterification	4	9	44.4444444444444	0.00553996749543528	0.115056377563093	1	1	0.999999835438707	0.999999835438707	1
down	COL1A1; COL5A1; SERPINH1; P3H3;	GO:0032964~collagen biosynthetic process	4	9	44.4444444444444	0.00553996749543528	0.115056377563093	1	1	0.999999835438707	0.999999835438707	1
down	KRT6A; HRG; CFHR1; CFHR5;	GO:0051838~cytolysis by host of symbiont cells	4	9	44.4444444444444	0.00553996749543528	0.115056377563093	1	1	0.999999835438707	0.999999835438707	1
down	TCF21; ASS1; WT1; STRA6;	GO:0060539~diaphragm development	4	9	44.4444444444444	0.00553996749543528	0.115056377563093	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; BMP5; DAB2; GDF6; INHBE; GDF5; INHA; LEFTY1; LEFTY2;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	9	48	18.75	0.00573926997432006	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	MATN3; OBSL1; WFS1; STC2; FSTL3; C3; PENK; APOE; FGG; LAMC1; BMP4; SCG2; IGFBP3; CDH2; IGFBP4; HRC; IGFBP5; TNC; FBN1; LAMB2; MFGE8; FSTL1; DMP1; IGFBP7; NOTUM; AMTN; ASB18; FBXO17; MXRA8; CHRDL1; CCDC8; FBXL7; SERPINA10; HIF3A; ASB4;	GO:0043687~post-translational protein modification	35	344	10.1744186046512	0.00584673023948712	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	HAND2; TWIST1; PITX2;	GO:0003253~cardiac neural crest cell migration involved in outflow tract morphogenesis	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	MUSK; SIX1; SIX4;	GO:0008582~regulation of synaptic growth at neuromuscular junction	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	FGF7; MSX1; HAND2;	GO:0010463~mesenchymal cell proliferation	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	DGKI; DRD1; SHANK1;	GO:0046959~habituation	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	SLIT3; SLIT2; IGFBP7;	GO:0051414~response to cortisol	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	PALM; DRD2; RGS4;	GO:0060160~negative regulation of dopamine receptor signaling pathway	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	FGF10; FGFR1; FGF7;	GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	CXCL10; FGF1; ADAMTS12;	GO:1901509~regulation of endothelial tube morphogenesis	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	FGF18; FGF2; FGFR1;	GO:2000546~positive regulation of endothelial cell chemotaxis to fibroblast growth factor	3	4	75	0.00593003671023662	0.115841212171256	1	1	0.999999835438707	0.999999835438707	1
down	GLI2; GLI3; HOXA11; GAS1; DMBX1; STRA6;	GO:0048589~developmental growth	6	23	26.0869565217391	0.00603744567413123	0.117358426749369	1	1	0.999999835438707	0.999999835438707	1
down	GLI2; FST; BMP5; NRG3; SIX1; ZIC1; TBX5;	GO:0007389~pattern specification process	7	31	22.5806451612903	0.00606744209110643	0.117363365154441	1	1	0.999999835438707	0.999999835438707	1
down	MEIS2; ZNF536; FOXS1; TCF21; LEFTY1; WFS1; IL33; IGF2; GLI2; GLI3; NR2F1; FGFR1; BMP4; WT1; FST; NR2F2; EDNRB; MSX1; HOXC8; PCGF2; MSX2; MMP12; PRRX1; FOXG1; PCBP3; FOXL2; ISL1; NKX6-1; EMX2; EN1; FOXF1; TBX2; HIC1; ANKRD1; SIX1; TWIST1; ALX1; KANK2; MYOCD; OSR2; ESX1; GLIS1; GLIS3; DMBX1; OSR1; HOXB13; GATA6; CREB3L1; FOXC2; SCRT1; PEG3; MYOZ1; PRDM6; SALL1; LMCD1; FBLN5; FOXD3; PURG; LOXL2; HES7; ZFPM2; NR0B1; TBX4; DLX2; TBX5; TBX18; ANKRD33; HES2; RIPPLY1; RIPPLY2; ID4; VRTN; ZFHX4;	GO:0000122~negative regulation of transcription by RNA polymerase II	73	847	8.61865407319953	0.00615213762906419	0.118421146752621	1	1	0.999999835438707	0.999999835438707	1
down	STC2; CXCL10; TYR; STC1; CYP24A1;	GO:0033280~response to vitamin D	5	16	31.25	0.0064334350324623	0.122639297768581	1	1	0.999999835438707	0.999999835438707	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00665450378020971	0.702826490754235	1	1	1	1	1
down	MEIS2; FGF10; WFS1; ISL1; NKX6-1; FOXF1;	GO:0031016~pancreas development	6	24	25	0.00717790737862423	0.134876297695482	1	1	0.999999835438707	0.999999835438707	1
down	HPN; GLI2; PTK7; SIX1; FRZB; CTHRC1;	GO:0090103~cochlea morphogenesis	6	24	25	0.00717790737862423	0.134876297695482	1	1	0.999999835438707	0.999999835438707	1
down	SIX1; NR2F2; NR2F1; EYA4; SIX4; SIX2; SIX5; ROR2; RXRG;	GO:0048856~anatomical structure development	9	50	18	0.00721896455878379	0.135004901179909	1	1	0.999999835438707	0.999999835438707	1
down	SFRP4; FST; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	4	10	40	0.00739871683223403	0.136426806635493	1	1	0.999999835438707	0.999999835438707	1
down	IGFBP3; IGFBP4; IGFBP5; NKX6-1;	GO:0044342~type B pancreatic cell proliferation	4	10	40	0.00739871683223403	0.136426806635493	1	1	0.999999835438707	0.999999835438707	1
down	FGF18; COL11A1; MSX2; COMP; SULF1;	GO:0002063~chondrocyte development	5	17	29.4117647058824	0.00792871708016651	0.141568857911027	1	1	0.999999835438707	0.999999835438707	1
down	SLC16A2; CTSK; DIO3; IYD; CGA;	GO:0006590~thyroid hormone generation	5	17	29.4117647058824	0.00792871708016651	0.141568857911027	1	1	0.999999835438707	0.999999835438707	1
down	KCNK9; KCNK2; KCNK3; KCNK12; KCNK15;	GO:0030322~stabilization of membrane potential	5	17	29.4117647058824	0.00792871708016651	0.141568857911027	1	1	0.999999835438707	0.999999835438707	1
down	GRM6; PDGFRB; CCL2; CXCL12; STC1;	GO:0090280~positive regulation of calcium ion import	5	17	29.4117647058824	0.00792871708016651	0.141568857911027	1	1	0.999999835438707	0.999999835438707	1
down	DCLK1; CLDN18; DCLK2; DCLK3; TMEM98;	GO:1900181~negative regulation of protein localization to nucleus	5	17	29.4117647058824	0.00792871708016651	0.141568857911027	1	1	0.999999835438707	0.999999835438707	1
down	FXYD1; CACNA1H; CHRM2; TPM1; DES; TBX2; HSPB7;	GO:0008016~regulation of heart contraction	7	33	21.2121212121212	0.0080937525418503	0.142580122902416	1	1	0.999999835438707	0.999999835438707	1
down	SAA1; CCL8; CCL25; CCL2; CCL7; CCL11; CCL13;	GO:0048247~lymphocyte chemotaxis	7	33	21.2121212121212	0.0080937525418503	0.142580122902416	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; ADAMTS12; GATA6; PHOX2B; TNMD; TMEM100; ADAMTS7;	GO:0071773~cellular response to BMP stimulus	7	33	21.2121212121212	0.0080937525418503	0.142580122902416	1	1	0.999999835438707	0.999999835438707	1
down	TGFB1I1; COL1A1; BMP4; ISL1; DAB2; TWIST1; ALX1; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	8	42	19.047619047619	0.00828945993228025	0.14446022503034	1	1	0.999999835438707	0.999999835438707	1
down	CYP1A1; WT1; FBN1; EFEMP1; CACNA1C; PITX2; FOXC2; STRA6;	GO:0043010~camera-type eye development	8	42	19.047619047619	0.00828945993228025	0.14446022503034	1	1	0.999999835438707	0.999999835438707	1
up	HBZ; HBD; HBG1; HBG2; HBA1; HBM;	GO:0015671~oxygen transport	6	14	42.8571428571429	0.00834346500158301	0.824914757113033	1	1	1	1	1
down	GALR3; GABBR2; EDNRB; GALR1; DRD2; PALM;	GO:0007194~negative regulation of adenylate cyclase activity	6	25	24	0.008466139583721	0.144620722066507	1	1	0.999999835438707	0.999999835438707	1
down	SERPINB7; PDGFRB; BMP4; SCX; CREB3L1; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	6	25	24	0.008466139583721	0.144620722066507	1	1	0.999999835438707	0.999999835438707	1
down	ALOX12B; CLDN1; FLG; FLG2; ABCA12; ALOXE3;	GO:0061436~establishment of skin barrier	6	25	24	0.008466139583721	0.144620722066507	1	1	0.999999835438707	0.999999835438707	1
down	SLITRK1; SLITRK2; LRRC4C; LRRC4B; GPC6; LRFN5;	GO:0099560~synaptic membrane adhesion	6	25	24	0.008466139583721	0.144620722066507	1	1	0.999999835438707	0.999999835438707	1
down	WFS1; GABRG3; GABRB2; CHRNA1; GABRA1; GABRA6; GABRR3; GABRA2; GLRB;	GO:0050877~nervous system process	9	52	17.3076923076923	0.00897361508638395	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	FGFR4; LRP1; DDR2;	GO:0010715~regulation of extracellular matrix disassembly	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	LOX; LOXL2; LOXL1;	GO:0018057~peptidyl-lysine oxidation	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	APOE; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	PDGFRB; LOX; PDGFRL;	GO:0035791~platelet-derived growth factor receptor-beta signaling pathway	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	FZD7; MYOC; FZD10;	GO:0038031~non-canonical Wnt signaling pathway via JNK cascade	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	DRD2; DRD1; GDNF;	GO:0051584~regulation of dopamine uptake involved in synaptic transmission	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	NRP2; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	FOXF1; MYOCD; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	GABBR2; ADRA1A; ADRA1B;	GO:0150099~neuron-glial cell signaling	3	5	60	0.00907544317579534	0.148596260463437	1	1	0.999999835438707	0.999999835438707	1
down	MUSK; COL4A1; CHRNA1; TNC; LAMB2; PDZRN3; TMEFF1;	GO:0007528~neuromuscular junction development	7	34	20.5882352941176	0.00927548455889082	0.151244058137947	1	1	0.999999835438707	0.999999835438707	1
down	CDH2; CDH11; CDH15; CDH18; CADM3; CDH10; NUMBL; CDH19;	GO:0034332~adherens junction organization	8	43	18.6046511627907	0.00933672808487829	0.151616168818641	1	1	0.999999835438707	0.999999835438707	1
down	FGF10; BMP4; OSR2; OSR1;	GO:0001823~mesonephros development	4	11	36.3636363636364	0.00962551458330285	0.152299929491289	1	1	0.999999835438707	0.999999835438707	1
down	WT1; NR0B1; OSR1; SALL1;	GO:0008406~gonad development	4	11	36.3636363636364	0.00962551458330285	0.152299929491289	1	1	0.999999835438707	0.999999835438707	1
down	COL4A1; DDR2; COL1A1; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	4	11	36.3636363636364	0.00962551458330285	0.152299929491289	1	1	0.999999835438707	0.999999835438707	1
down	GLI3; HAND2; BNC2; SIX4;	GO:0043586~tongue development	4	11	36.3636363636364	0.00962551458330285	0.152299929491289	1	1	0.999999835438707	0.999999835438707	1
down	COL1A1; COL1A2; CDSN; ERRFI1;	GO:0043589~skin morphogenesis	4	11	36.3636363636364	0.00962551458330285	0.152299929491289	1	1	0.999999835438707	0.999999835438707	1
down	DES; KRT20; KRT17; KRT25; TCHH;	GO:0045109~intermediate filament organization	5	18	27.7777777777778	0.00964900719027428	0.152299929491289	1	1	0.999999835438707	0.999999835438707	1
down	GREM1; AGT; GDNF; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	5	18	27.7777777777778	0.00964900719027428	0.152299929491289	1	1	0.999999835438707	0.999999835438707	1
down	NCAN; DCN; BGN; CSPG4; CHSY3; CHST9;	GO:0030206~chondroitin sulfate biosynthetic process	6	26	23.0769230769231	0.00991195974532799	0.154595229861914	1	1	0.999999835438707	0.999999835438707	1
down	PITX3; PENK; DRD2; TACR3; RGS4; PPP1R1B;	GO:0043278~response to morphine	6	26	23.0769230769231	0.00991195974532799	0.154595229861914	1	1	0.999999835438707	0.999999835438707	1
down	GLP2R; ASS1; ADCY8; GCGR; ADCY2; FGF21;	GO:0071377~cellular response to glucagon stimulus	6	26	23.0769230769231	0.00991195974532799	0.154595229861914	1	1	0.999999835438707	0.999999835438707	1
down	AKR1B15; AKR1B10; RBP4; CYP1A1; ALDH1A3; ADH1C; ADH1A; ADH1B;	GO:0042572~retinol metabolic process	8	44	18.1818181818182	0.0104793777545014	0.16090126310997	1	1	0.999999835438707	0.999999835438707	1
down	UCHL1; DRD2; DRD1; GLRB; ZIC1; KLHL1;	GO:0007628~adult walking behavior	6	27	22.2222222222222	0.0115249503908428	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	ODAM; DMP1; DDR2; TMEM119; AMTN; DSPP;	GO:0031214~biomineral tissue development	6	27	22.2222222222222	0.0115249503908428	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	FGF10; FGF7; ANK2; ANGPT1; GPIHBP1; FBLN5;	GO:0034394~protein localization to cell surface	6	27	22.2222222222222	0.0115249503908428	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	CDH2; CDH19; CDH18; CDH11; CDH15; CDH10;	GO:0044331~cell-cell adhesion mediated by cadherin	6	27	22.2222222222222	0.0115249503908428	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	DDAH1; AGT; APOE; NPY2R; MT1M;	GO:0007263~nitric oxide mediated signal transduction	5	19	26.3157894736842	0.0116092230770879	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	DLX2; OSR2; OSR1; DLX6; CDX1;	GO:0009790~embryo development	5	19	26.3157894736842	0.0116092230770879	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	IGF1; PDGFRB; POSTN; SEMA6D; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	5	19	26.3157894736842	0.0116092230770879	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	MGP; COMP; TWIST1; DDR2; OMD;	GO:0030500~regulation of bone mineralization	5	19	26.3157894736842	0.0116092230770879	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	PDGFRA; WT1; BMP5; LHCGR; ROR2;	GO:0030539~male genitalia development	5	19	26.3157894736842	0.0116092230770879	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	SERPINE2; NTF4; GABRB2; ISL1; SULF1;	GO:0060384~innervation	5	19	26.3157894736842	0.0116092230770879	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	NUPR1; ANKRD1; SCX; ANKRD33; SMYD1; PHOX2B; MYOG; MYF6;	GO:0035914~skeletal muscle cell differentiation	8	45	17.7777777777778	0.0117222921254786	0.170686954712688	1	1	0.999999835438707	0.999999835438707	1
down	NCAN; DCN; BGN; CSPG4;	GO:0030208~dermatan sulfate biosynthetic process	4	12	33.3333333333333	0.0122455970643868	0.176354474511205	1	1	0.999999835438707	0.999999835438707	1
down	ASIC2; LRRTM1; NLGN2; SHANK1;	GO:0035418~protein localization to synapse	4	12	33.3333333333333	0.0122455970643868	0.176354474511205	1	1	0.999999835438707	0.999999835438707	1
down	ADRA1A; CACNA2D1; CACNA1C; JPH2;	GO:0060402~calcium ion transport into cytosol	4	12	33.3333333333333	0.0122455970643868	0.176354474511205	1	1	0.999999835438707	0.999999835438707	1
down	CLDN1; F10; CGA; COL1A1; IGF1; FGF1; F7; PDGFRB; PDGFRA; NTF3; DRD1; CCL11; CCL7; DAB2; ROR2; FOXF1; GPNMB; LRRC15; CEMIP; TWIST2; MYOC; CXCL12; SEMA6D; SEMA3E;	GO:0030335~positive regulation of cell migration	24	226	10.6194690265487	0.0128368058347802	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	MYOG; ANGPT1; SIX1;	GO:0014842~regulation of skeletal muscle satellite cell proliferation	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	DCN; BGN; EGFLAM;	GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	GDNF; CXCL12; NPY2R;	GO:0033603~positive regulation of dopamine secretion	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	HAND2; GPNMB; DDR2;	GO:0034103~regulation of tissue remodeling	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	FGF10; MYOG; MYF6;	GO:0042693~muscle cell fate commitment	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	CILP; BMP5; IGFBP5;	GO:0043569~negative regulation of insulin-like growth factor receptor signaling pathway	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; MSX2; TWIST1;	GO:0060363~cranial suture morphogenesis	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; MSX1; MSX2;	GO:0061312~BMP signaling pathway involved in heart development	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	WT1; LHCGR; GATA6;	GO:0071371~cellular response to gonadotropin stimulus	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	GREM1; SLIT2; NBL1;	GO:0090027~negative regulation of monocyte chemotaxis	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	KCNA1; GRIK2; GRIK3;	GO:0099505~regulation of presynaptic membrane potential	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	TPM1; PRKG1; MYOCD;	GO:1904753~negative regulation of vascular associated smooth muscle cell migration	3	6	50	0.0130230643290232	0.179055790391379	1	1	0.999999835438707	0.999999835438707	1
down	SLIT3; SLIT2; CACNA1H; IGFBP7; ROBO2; CCKAR; NPFFR2; HCRTR2;	GO:0032870~cellular response to hormone stimulus	8	46	17.3913043478261	0.0130703114185714	0.179081419644732	1	1	0.999999835438707	0.999999835438707	1
up	S100A8; S100A9; ELANE; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.0131817984156422	1	1	1	1	1	1
up	ELANE; CTSG; IFNL1; IFNL2; GPR151;	GO:0050778~positive regulation of immune response	5	11	45.4545454545455	0.0131817984156422	1	1	1	1	1	1
down	BMP4; MSX1; MSX2; TWIST1; OSR2; OSR1;	GO:0035116~embryonic hindlimb morphogenesis	6	28	21.4285714285714	0.0133143967916489	0.180047524886817	1	1	0.999999835438707	0.999999835438707	1
down	MMP2; COL4A2; COL11A1; COL6A1; COL8A1; COL12A1;	GO:0035987~endodermal cell differentiation	6	28	21.4285714285714	0.0133143967916489	0.180047524886817	1	1	0.999999835438707	0.999999835438707	1
up	AIRE; S100A8; S100A9;	GO:0032602~chemokine production	3	3	100	0.0133287996950104	1	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0133287996950104	1	1	1	1	1	1
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0149553277368857	1	1	1	1	1	1
down	BMP4; MSX1; MSX2; TMEM100;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	4	13	30.7692307692308	0.015280993006154	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	COL1A2; TNXB; TNS2; P3H3;	GO:0032963~collagen metabolic process	4	13	30.7692307692308	0.015280993006154	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	GLI3; TBX4; EVX2; PKDCC;	GO:0035108~limb morphogenesis	4	13	30.7692307692308	0.015280993006154	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	NGF; NTF4; BDNF; NTF3;	GO:0038180~nerve growth factor signaling pathway	4	13	30.7692307692308	0.015280993006154	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	TRPA1; CXCL12; BACE1; KCNA1;	GO:0050966~detection of mechanical stimulus involved in sensory perception of pain	4	13	30.7692307692308	0.015280993006154	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	ACTC1; SGCD; SGCG; SGCZ;	GO:0060047~heart contraction	4	13	30.7692307692308	0.015280993006154	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	LEFTY1; COL5A1; FAT4; ALPK2; DLC1; MESP2; MESP1;	GO:0003007~heart morphogenesis	7	38	18.4210526315789	0.015281383864207	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	GRID2; SHC3; GRIK4; GRIA1; SLC17A6; GRIK3; GRIK2;	GO:0035249~synaptic transmission, glutamatergic	7	38	18.4210526315789	0.015281383864207	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	KERA; OGN; LUM; PRELP; FMOD; OMD;	GO:0018146~keratan sulfate biosynthetic process	6	29	20.6896551724138	0.0152892286750592	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	PITX3; FGFR1; EN2; CMA1; MSX1; EN1;	GO:0030901~midbrain development	6	29	20.6896551724138	0.0152892286750592	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	CYP1A1; AQP1; BACE1; MT3; MT1A; MT1M;	GO:0071280~cellular response to copper ion	6	29	20.6896551724138	0.0152892286750592	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	SMAD6; NUPR1; GREM1; SLC25A27; NGF; IGF1; HPN; PDGFRB; GLI2; GLI3; BMP4; MIF; EPCAM; WT1; POU3F3; NME2; EDNRB; MT3; MSX1; AQP1; ADORA1; MSX2; GDNF; PTGFR; COMP; ADAMTS20; ACTC1; DAB2; ANGPT1; RGN; TWIST1; ASIC2; SCX; OSR1; TWIST2; GATA6; TSLP; BIRC7; FAIM2; ANGPTL4; ARNT2; FMN2; SIX4; VIP;	GO:0043066~negative regulation of apoptotic process	44	489	8.99795501022495	0.0153467573099464	0.197902955375975	1	1	0.999999835438707	0.999999835438707	1
down	TGFB1I1; FZD7; PITX3; AGT; IFNA2; COL1A1; APOE; IGF1; FGF2; GLI2; GLI3; BMP4; WT1; POU3F3; FGF7; NME2; PAX3; NR2F2; MT3; HOXA11; FOXL2; HAND2; ESRRG; ACTA2; DAB2; NDP; ROR2; FOXF1; FOXF2; SIX1; ALX1; ZIC1; GDF6; SCX; RFX6; MYOCD; OSR2; CTCFL; NAT14; GATA6; ATOH8; TBX5; FOXC2; MESP1; EBF3; ARNT2; SALL1; SIX4; FZD4; ZFHX4;	GO:0045893~positive regulation of transcription, DNA-templated	50	570	8.7719298245614	0.0154771363838756	0.198934137364082	1	1	0.999999835438707	0.999999835438707	1
up	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.0157544719873282	1	1	1	1	1	1
down	TRABD2B; TGFB1I1; WNT2; DRD2; CPE; DAB2; NDP; HIC1; RSPO4; RSPO1; CPZ; NOTUM; SHISA6; AMER2; AMER3; NKD2; FERMT2; DACT3; ADGRA2; RSPO3; FZD4;	GO:0016055~Wnt signaling pathway	21	194	10.8247422680412	0.0159249322787179	0.203364992789065	1	1	0.999999835438707	0.999999835438707	1
down	GIP; NTF4; GDNF; CXCL12; EN1; EPS8; PREX2; DMBX1;	GO:0008344~adult locomotory behavior	8	48	16.6666666666667	0.0161006966759877	0.204946287365959	1	1	0.999999835438707	0.999999835438707	1
up	S100A8; S100A9; CTSG; DEFA4; DEFA3; S100A12; HAMP; CLEC6A;	GO:0050832~defense response to fungus	8	28	28.5714285714286	0.0166751250076395	1	1	1	1	1	1
up	CCL21; TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	6	17	35.2941176470588	0.0170309673479184	1	1	1	1	1	1
down	DRD1; AGTR1; GRM1; KISS1; LPAR4; DRD2; GPR17;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	7	39	17.9487179487179	0.0171346373023902	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
up	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.0172554624351804	1	1	1	1	1	1
down	SERPINE2; CDH2; GRM1; DGKI; GRM5; GRM6;	GO:0051966~regulation of synaptic transmission, glutamatergic	6	30	20	0.0174579663083199	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	MSX1; CDX1; RIPPLY2; SFRP4; OSR2; PAPPA2;	GO:0060349~bone morphogenesis	6	30	20	0.0174579663083199	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	FGG; SCG2; IL11; ANGPT1; ANGPTL4; FGF21;	GO:2000352~negative regulation of endothelial cell apoptotic process	6	30	20	0.0174579663083199	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	SEMA3E; GRM5; DRP2; LRRTM1; CBLN2; NLGN2; PCDHGC4; PPFIA2;	GO:0050808~synapse organization	8	49	16.3265306122449	0.0177923581783069	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	C3; GIP; CLIP3;	GO:0010828~positive regulation of glucose transmembrane transport	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	MYOG; ACTN3; TRIM63;	GO:0014732~skeletal muscle atrophy	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	ISL1; ISL2; HOXC10;	GO:0021520~spinal cord motor neuron cell fate specification	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	NPR2; ANTXR1; KCNU1;	GO:0022414~reproductive process	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	BDNF; HTR1B; ADORA1;	GO:0032229~negative regulation of synaptic transmission, GABAergic	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	HOXC13; RSPO4; KRT84;	GO:0035878~nail development	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	ALDH1A3; GLRB; SHANK1;	GO:0060013~righting reflex	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	WT1; FOXC2; KLF15;	GO:0072112~glomerular visceral epithelial cell differentiation	3	7	42.8571428571429	0.017800550865663	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	SERPINA5; SPAM1; CRISP1; ADAM2;	GO:0007342~fusion of sperm to egg plasma membrane involved in single fertilization	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	APELA; ADRA1A; HAND2; SCUBE1;	GO:0007512~adult heart development	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	GIP; SERPINF1; SST; ASIC2;	GO:0010447~response to acidic pH	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	NCAN; DCN; BGN; CSPG4;	GO:0030207~chondroitin sulfate catabolic process	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	DRD2; NPR1; NPPB; EDNRB;	GO:0035810~positive regulation of urine volume	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	PDGFRB; LRP1; TBX2; SIX1;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	PDGFRB; BMP4; ITGA8; STRA6;	GO:0048745~smooth muscle tissue development	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	IGF2; CDH2; IGFBP5; POPDC3;	GO:0051146~striated muscle cell differentiation	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	ASS1; F7; NME2; IGFBP5;	GO:0060416~response to growth hormone	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	MMP2; MMP3; CALCR; MMP12;	GO:1904645~response to amyloid-beta	4	14	28.5714285714286	0.0187504345113252	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	DRD2; DRD1; ADORA1; NOX3; ADRB3;	GO:0001659~temperature homeostasis	5	22	22.7272727272727	0.0190647784186031	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	MYOG; IGFBP3; CXCL9; SMYD1; MYF6;	GO:0045663~positive regulation of myoblast differentiation	5	22	22.7272727272727	0.0190647784186031	0.209611136953593	1	1	0.999999835438707	0.999999835438707	1
down	IGF1; GLI3; BMP4; MSX2; PRKD1; DDR2; TMEM119; NELL1; CTHRC1;	GO:0045669~positive regulation of osteoblast differentiation	9	60	15	0.0193382636892758	0.211381685645104	1	1	0.999999835438707	0.999999835438707	1
down	APOE; SCG2; NR2F2; SULF1; ATOH8; TNMD;	GO:0001937~negative regulation of endothelial cell proliferation	6	31	19.3548387096774	0.0198286712103573	0.214955869769422	1	1	0.999999835438707	0.999999835438707	1
down	AGT; DRD2; HRC; ANK2; HCN4; SCN10A;	GO:0002027~regulation of heart rate	6	31	19.3548387096774	0.0198286712103573	0.214955869769422	1	1	0.999999835438707	0.999999835438707	1
down	COL1A1; MMP2; PDGFRA; MSX1; SCX; STRA6;	GO:0060325~face morphogenesis	6	31	19.3548387096774	0.0198286712103573	0.214955869769422	1	1	0.999999835438707	0.999999835438707	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0217078956449263	1	1	1	1	1	1
down	WNT2; FGFR1; PRRX1; FOXF1; CHRD;	GO:0002053~positive regulation of mesenchymal cell proliferation	5	23	21.7391304347826	0.022114780676293	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	GRID2; GRIA1; GRIK2; GRIK3; GRIK4;	GO:0035235~ionotropic glutamate receptor signaling pathway	5	23	21.7391304347826	0.022114780676293	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	APOE; DAB2; LRP1; CLIP3; CALY;	GO:0045807~positive regulation of endocytosis	5	23	21.7391304347826	0.022114780676293	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	APOE; COMP; PRRX1; FOXC2; STRA6;	GO:0048844~artery morphogenesis	5	23	21.7391304347826	0.022114780676293	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	CCL2; DRD1; ROR2; NLGN2; SHANK1;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	5	23	21.7391304347826	0.022114780676293	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	BRINP1; PENK; DRD1; BDNF; NPY2R; GRIK2;	GO:0001662~behavioral fear response	6	32	18.75	0.0224089016703251	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	FGF10; AGT; LIF; BGN; FOXC2; RSPO3;	GO:0001974~blood vessel remodeling	6	32	18.75	0.0224089016703251	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	PLG; CTSK; ADAMTS12; FAP; ADAMTS7; CTSV;	GO:0051603~proteolysis involved in cellular protein catabolic process	6	32	18.75	0.0224089016703251	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	FOXS1; GREM1; IFNA2; GLI3; BMP4; WT1; POU3F3; MYF6; NR2F2; MT3; MSX2; CDKN2A; ID4; NR0B1; FOXG1; FOXL2; DAB2; RUNX1T1; RIPPLY1; FOXF2; TBX2; TWIST1; FOXD1; NKAPL; ERN2; SCX; PASD1; ESX1; SMYD1; DMBX1; TWIST2; ZFPM2; GATA6; CREB3L1; ATOH8; MESP1; TCEAL7; SALL1; SIX4; MAGEL2; LOXL2; SIX2; SIX5; SIX1; ALX1; ZNF503;	GO:0045892~negative regulation of transcription, DNA-templated	46	530	8.67924528301887	0.0226545924935502	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	FGF5; CDH2; PHOX2B; KLF15;	GO:0010001~glial cell differentiation	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	SERPINE2; GAS1; CHAC1; TMEM98;	GO:0010955~negative regulation of protein processing	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	SLCO1A2; SLC22A11; SLCO1B1; SLC22A10;	GO:0015711~organic anion transport	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	GIP; SCT; SCTR; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	GFRA3; GDNF; HAND2; PHOX2B;	GO:0048485~sympathetic nervous system development	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	ACR; LOX; SST; ACTA1;	GO:0048545~response to steroid hormone	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	PGR; EDNRB; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	OBSL1; PDGFRB; PDGFRA; ACTC1;	GO:0055003~cardiac myofibril assembly	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	RBP4; HOXA11; FOXL2; MYOCD;	GO:0060065~uterus development	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	BRINP1; SRPX2; GLI3; SHANK1;	GO:0071625~vocalization behavior	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	FGF2; PDGFRB; FGFR4; NOX4;	GO:2000573~positive regulation of DNA biosynthetic process	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	NKX6-1; UNC5D; SCRT1; CAMK2A;	GO:2001222~regulation of neuron migration	4	15	26.6666666666667	0.0226693304348144	0.229367122809687	1	1	0.999999835438707	0.999999835438707	1
down	TNFRSF11B; SMAD6; F7; PDGFRB; GLI3; GAL; GHRHR; TPH2; GATA6;	GO:0043627~response to estrogen	9	62	14.5161290322581	0.0229119303817708	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	NGF; NBL1; CNTNAP1; NYAP1; NTF3; NRK; DCLK1; NTF4; BDNF;	GO:0048812~neuron projection morphogenesis	9	62	14.5161290322581	0.0229119303817708	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	CRLF1; CXCL10; COL1A2; MMP2; MMP3; FGF2; SAA1; CCL2; LIF; VCAM1; IL11; CNTFR; CCL11; IL13RA2; TWIST1; CTF1; IL17REL; IL17RD; NDN; OSMR; IL1RAPL2; IL20RA; FZD4; NUMBL; IFNA1; IFNA2; IFNA8;	GO:0019221~cytokine-mediated signaling pathway	27	278	9.71223021582734	0.022959599262489	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	MSX2; DDR2; BNC2;	GO:0003416~endochondral bone growth	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	APOE; PDGFRA; C1QTNF1;	GO:0010544~negative regulation of platelet activation	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	WFS1; ATP6V1B1; SHANK1;	GO:0042048~olfactory behavior	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	DRD2; HTR1B; EN1;	GO:0042756~drinking behavior	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	PLG; CSPG4; MMP2;	GO:0048771~tissue remodeling	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	NRP2; SLIT3; SLIT2;	GO:0048846~axon extension involved in axon guidance	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	AQP1; SCNN1G; AQP4;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	COL1A1; MMP2; MSX2;	GO:0060346~bone trabecula formation	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	FAP; PTGIS; DLC1;	GO:1900119~positive regulation of execution phase of apoptosis	3	8	37.5	0.0234217451898835	0.229905986366369	1	1	0.999999835438707	0.999999835438707	1
down	IGF2; TPM1; PDGFRB; GLI2; GLI3; FGFR1; C6; PDGFRA; MSX1; PCGF2; HSD17B2; HAND2; FOXF1; ANGPT1; TWIST1; ZFPM2; GATA6; SLC5A7; ARNT2; TMEM100; FOXD3;	GO:0001701~in utero embryonic development	21	203	10.3448275862069	0.0239363281405424	0.233793937729159	1	1	0.999999835438707	0.999999835438707	1
down	FOXS1; IGF2; DRD2; DIO3; SLC6A3; GHRHR;	GO:0040018~positive regulation of multicellular organism growth	6	33	18.1818181818182	0.0252056731881606	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	AGT; IGF1; MMP2; FGF2; IGFBP5; HTR1B;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	6	33	18.1818181818182	0.0252056731881606	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	GREM1; DRD2; NTF3; ANGPT1; SFRP4;	GO:0002092~positive regulation of receptor internalization	5	24	20.8333333333333	0.0254642254683082	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	HPN; BMP5; VASN; DACT3; TBX5;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.0254642254683082	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	HMX3; KCNK3; UNC5C; COL4A1; MT3; NES; RGS4; ITGA8; FOXG1; HSPG2; DLX2; ZIC1; DMBX1; SLC38A3; ARNT2; ROBO2; PCDH18; EMX2; SCTR; SCT; CDH2; ADGRL2;	GO:0007420~brain development	22	217	10.1382488479263	0.0254729032814124	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	FOXS1; COL1A1; COL1A2; COL5A1; FOXF1; STRA6; ANTXR1;	GO:0001568~blood vessel development	7	43	16.2790697674419	0.0261323915927472	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	TNFRSF11B; KCNK3; CYP1A1; GIP; DRD2; DRD1; GAL; BDNF; LOX; AQP1; ADRA1A; NNMT; S100A10; SST; EMX2; CA9; GATA6; TIMP4; GABRG3; WFDC1;	GO:0042493~response to drug	20	193	10.3626943005181	0.0266328456658212	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	SCT; GLI3; HTR5A; ID4; EPHA5; DLX2; KCNA1; CDK5R2; DCLK2;	GO:0021766~hippocampus development	9	64	14.0625	0.0269336448318631	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	GRID2; GRIK2; GRIK3; GRIK4;	GO:0007215~glutamate receptor signaling pathway	4	16	25	0.0270497916704699	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	GRM6; GRM5; GRIK3; GRM1;	GO:0007216~G protein-coupled glutamate receptor signaling pathway	4	16	25	0.0270497916704699	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	ASS1; PENK; WT1; IGFBP5; AQP1; STC1; NOX4; HCN4;	GO:0071320~cellular response to cAMP	8	54	14.8148148148148	0.0281901403203485	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	WFS1; ATP6V1B1; AQP1; ADCY8; AQP4; ADCY2;	GO:0003091~renal water homeostasis	6	34	17.6470588235294	0.0282254238903157	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; MSX1; MSX2; GDF5; FOXD1; SULF1;	GO:0030513~positive regulation of BMP signaling pathway	6	34	17.6470588235294	0.0282254238903157	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	COL1A1; BMP4; MSX1; SIX1; SIX4; PYGO1;	GO:0034504~protein localization to nucleus	6	34	17.6470588235294	0.0282254238903157	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	ADAMTS2; COL3A1; COL5A2; COL5A1; COMP; COL1A1;	GO:0043588~skin development	6	34	17.6470588235294	0.0282254238903157	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	EDNRB; GDNF; GBX2; ISL1; ALX1; SEMA3E; SEMA6D;	GO:0001755~neural crest cell migration	7	44	15.9090909090909	0.02880442896911	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	SMAD6; GREM1; IGFBP5; HAND2; TWIST1; TWIST2; CHRD;	GO:0045668~negative regulation of osteoblast differentiation	7	44	15.9090909090909	0.02880442896911	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	COL11A1; PDGFRA; PCGF2; SIX1; OSR2; ALX1; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	7	44	15.9090909090909	0.02880442896911	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	HMX3; FOXS1; ALDH1A3; CNTNAP1; IGDCC3; NLGN2; SHANK1;	GO:0050885~neuromuscular process controlling balance	7	44	15.9090909090909	0.02880442896911	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	DHRS7C; AKR1B15; AKR1B10; ALOX12B; GPX5; BBOX1; CH25H; CYP1A1; SOD3; CYP21A2; TYR; DAO; TYRP1; VCAM1; FMO3; PYCR1; HSD17B2; ALDH1A3; TDO2; DIO3; CYP4F8; AOX1; CYP24A1; LOXL1; PTGIS; ALDH1L2; ASPHD1; IYD; MOXD1; P4HA3; P3H3; TPH2; SDR9C7; ENOX1; GPX8; PXDN; COX4I2; HSD17B14; ALOXE3; VAT1L; NOX4; CYP39A1; CYP26A1; STEAP2; NOX3;	GO:0055114~oxidation-reduction process	45	526	8.55513307984791	0.0290844122250949	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	CYP26A1; ALDH1A3; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	5	25	20	0.0291214890862345	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	CTSV; STC2; LIF; STC1; PTGIS;	GO:0046697~decidualization	5	25	20	0.0291214890862345	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	HRG; THY1; S100A10; COL16A1; MYOC;	GO:0051894~positive regulation of focal adhesion assembly	5	25	20	0.0291214890862345	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	MBL2; MASP1; COLEC10;	GO:0001867~complement activation, lectin pathway	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; FOXF1; TBX5;	GO:0003197~endocardial cushion development	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	CRP; MBL2; SPON2;	GO:0008228~opsonization	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	MATN2; CSPG4; NDN;	GO:0008347~glial cell migration	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	NID1; WT1; SULF1;	GO:0032836~glomerular basement membrane development	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	CXCL12; COL16A1; FERMT2;	GO:0033622~integrin activation	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	GFRA3; GFRA1; SULF1;	GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	FGFR1; TWIST1; SALL1;	GO:0042473~outer ear morphogenesis	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	DRD1; ADORA1; ANK2;	GO:0043268~positive regulation of potassium ion transport	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	DRD2; GHRHR; KISS1;	GO:0060124~positive regulation of growth hormone secretion	3	9	33.3333333333333	0.0298886648888816	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	ADAMTS2; F7; GLI3; COMP; ADAMTS13; CPZ; CPE; PCSK2;	GO:0016485~protein processing	8	55	14.5454545454545	0.0306857117874504	0.243144214283693	1	1	0.999999835438707	0.999999835438707	1
down	PITX3; DRD2; HTR1B; TACR3; RGS4; SLC6A3;	GO:0042220~response to cocaine	6	35	17.1428571428571	0.0314739849184572	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	SERPINE2; GIP; DRD1; SNAP25; NFATC4; LRRTM1; SHANK1;	GO:0060291~long-term synaptic potentiation	7	45	15.5555555555556	0.0316549924913911	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	KRT6A; TBX4; CA9; TBX5;	GO:0002009~morphogenesis of an epithelium	4	17	23.5294117647059	0.0319006991146941	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	FZD7; PLG; COL1A1; FZD4;	GO:0010812~negative regulation of cell-substrate adhesion	4	17	23.5294117647059	0.0319006991146941	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	BDNF; TMEM119; MYOCD; PLPP7;	GO:0010832~negative regulation of myotube differentiation	4	17	23.5294117647059	0.0319006991146941	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	C9; C8B; C7; C6;	GO:0019835~cytolysis	4	17	23.5294117647059	0.0319006991146941	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	APOE; APOC1; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	4	17	23.5294117647059	0.0319006991146941	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	CTSV; CTSK; KRT84; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.0319006991146941	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
down	DRD2; DRD1; SDK1; PPP1R1B;	GO:0048148~behavioral response to cocaine	4	17	23.5294117647059	0.0319006991146941	0.248284336699374	1	1	0.999999835438707	0.999999835438707	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0323370159071034	1	1	1	1	1	1
down	ODAM; SERPINA3; C3; IFNA2; CRP; CCL2; SCG2; MIF; GAL; IGFBP4; ADORA1; BDKRB1; CARD18; HSPG2; NFATC4; PRKD1; TRIL; NLRP10; SCUBE1; IL17D; RARRES2; NOX4; CCL11; CCL8; PTGFR; PTGER1; CCL7; AGTR1; CXCL9; CCL13; CXCL11; GGT5; CXCL10; CCL25;	GO:0006954~inflammatory response	34	381	8.9238845144357	0.0327799029575333	0.254624994233123	1	1	0.999999835438707	0.999999835438707	1
down	SIX1; NTF3; NGF; BDNF; NTF4;	GO:0045664~regulation of neuron differentiation	5	26	19.2307692307692	0.0330936716828939	0.256557226838309	1	1	0.999999835438707	0.999999835438707	1
down	FGF10; FGF7; EPS8; PTK7; SYDE1; ANTXR1; NRK; PARVA;	GO:0031532~actin cytoskeleton reorganization	8	56	14.2857142857143	0.0333284563407911	0.257870762197572	1	1	0.999999835438707	0.999999835438707	1
up	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.0341598086129582	1	1	1	1	1	1
down	CYP26A1; RBP4; PDGFRB; HSD17B2; IGFBP7; TRIML2; RXRG;	GO:0032526~response to retinoic acid	7	46	15.2173913043478	0.0346882295035388	0.267343268790945	1	1	0.999999835438707	0.999999835438707	1
down	TGFB1I1; SMAD6; HTRA3; VASN; ADAMTSL2; WFIKKN2; HTRA1; ASPN; EMILIN1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	9	68	13.2352941176471	0.0364185431479567	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
up	CA6; TAS2R38; TAS2R39; TAS2R40; TAS2R41; TAS2R50; TAS2R42; TAS2R13; RTP5;	GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste	9	40	22.5	0.0369945515633279	1	1	1	1	1	1
down	TCF21; FOXF1; COL16A1;	GO:0001763~morphogenesis of a branching structure	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	NR2F2; ADORA1; ADRA1A;	GO:0003084~positive regulation of systemic arterial blood pressure	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	CPE; NPY2R; FOXF1;	GO:0003214~cardiac left ventricle morphogenesis	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	NPR1; NPPB; NPR2;	GO:0007168~receptor guanylyl cyclase signaling pathway	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	BRINP1; SERPINF1; NPAS4;	GO:0007614~short-term memory	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	MYOG; ACTN3; SGCA;	GO:0014894~response to denervation involved in regulation of muscle adaptation	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	DRD2; DRD1; GDNF;	GO:0030432~peristalsis	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	COL5A1; MSX2; MMP12;	GO:0035313~wound healing, spreading of epidermal cells	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	COMP; STC1; DDR2;	GO:0035988~chondrocyte proliferation	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	DRD1; TACR3; SLC6A3;	GO:0042053~regulation of dopamine metabolic process	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	GPR37; DAO; SLC6A3;	GO:0042416~dopamine biosynthetic process	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	LIF; IL11; ADORA1;	GO:0046888~negative regulation of hormone secretion	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	PPFIA2; KIF1A; SDK1;	GO:0060998~regulation of dendritic spine development	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	HRG; DCN; ADGRA2;	GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway	3	10	30	0.0371932741069433	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	IGF1; FOXL1; CHST9; GAL3ST3;	GO:0030166~proteoglycan biosynthetic process	4	18	22.2222222222222	0.037227806233485	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	GLI2; EN2; BMP5; GBX2;	GO:0030902~hindbrain development	4	18	22.2222222222222	0.037227806233485	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	SLIT2; ISL1; ISL2; ROBO2;	GO:0031290~retinal ganglion cell axon guidance	4	18	22.2222222222222	0.037227806233485	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	SLC16A2; SLCO1A2; SLCO1C1; SLCO1B1;	GO:0043252~sodium-independent organic anion transport	4	18	22.2222222222222	0.037227806233485	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	NPY2R; MYOCD; ADRA1B; ADRA1A;	GO:0045987~positive regulation of smooth muscle contraction	4	18	22.2222222222222	0.037227806233485	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	BMP5; ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.037227806233485	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	TPM1; CNN1; PRKG1; MYOCD;	GO:1904706~negative regulation of vascular smooth muscle cell proliferation	4	18	22.2222222222222	0.037227806233485	0.275095362167288	1	1	0.999999835438707	0.999999835438707	1
down	GAL; HTR5A; EPHA5; GHRHR; ADCY2;	GO:0019933~cAMP-mediated signaling	5	27	18.5185185185185	0.0373865813009593	0.275237779502958	1	1	0.999999835438707	0.999999835438707	1
down	APOE; GIP; ADORA1; GPIHBP1; ANGPTL4;	GO:0070328~triglyceride homeostasis	5	27	18.5185185185185	0.0373865813009593	0.275237779502958	1	1	0.999999835438707	0.999999835438707	1
down	HMX3; ARGFX; DRGX; VGLL3; FSTL3; CGA; APOE; WT1; MYF6; HOXA11; HOXA13; HOXD11; ID4; IRX4; HOXC5; EVX2; MESP2; ISX; KLF17; ATOH7; ZBTB8B; ZSCAN1; ISL2; PKNOX2; DACH2; PITX2; PRRX2; HIF3A; DLX2; FOXD3; TCF24; BARX1; SCX; EMX2; SP9; RFX6; HMGB4; FOXC2; FOXL2; ANKRD1; DLX6; KLF18; EN1; NR2F1; EN2; FOXL1; TWIST1; KLF15; FOXS1; TCF21; CDX1; FOXD1; HAND2; ZIC4; SIM1; TWIST2; RXRG; NPAS4; NR2F2; ZIC1;	GO:0006357~regulation of transcription by RNA polymerase II	60	747	8.03212851405623	0.0378612861237541	0.277008611249493	1	1	0.999999835438707	0.999999835438707	1
down	GRID2; UMOD; CDH2; VCAM1; FAT4; CADM3; SCARF2;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	7	47	14.8936170212766	0.037907919431	0.277008611249493	1	1	0.999999835438707	0.999999835438707	1
down	VEGFD; IGF2; FGF1; FGF2; FGF5; FGF7; PROK1;	GO:0051781~positive regulation of cell division	7	47	14.8936170212766	0.037907919431	0.277008611249493	1	1	0.999999835438707	0.999999835438707	1
down	NOVA1; ACTN3; LAMA4; FOXC2; HOXC10; ADAMTS5; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	7	47	14.8936170212766	0.037907919431	0.277008611249493	1	1	0.999999835438707	0.999999835438707	1
down	DCN; HSD17B2; NDP; MC2R; HTRA1; PHLDA2;	GO:0001890~placenta development	6	37	16.2162162162162	0.0386776842946404	0.281590668314854	1	1	0.999999835438707	0.999999835438707	1
down	ASS1; SERPINA3; CRP; SAA1; SAA2; MBL2;	GO:0006953~acute-phase response	6	37	16.2162162162162	0.0386776842946404	0.281590668314854	1	1	0.999999835438707	0.999999835438707	1
down	PLPP1; DGKI; HTR1B; BDKRB1; LRP1;	GO:0007205~protein kinase C-activating G protein-coupled receptor signaling pathway	5	28	17.8571428571429	0.0420047296778088	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	PENK; COL3A1; CXCL12; CCL11; BACE1;	GO:0009314~response to radiation	5	28	17.8571428571429	0.0420047296778088	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	SEMA3E; CDKN2A; POSTN; MYOC;	GO:0001953~negative regulation of cell-matrix adhesion	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	SLC26A9; SLC17A4; SLC17A6; SLC17A9;	GO:0006820~anion transport	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	APOE; PLTP; LRP1; ABCA12;	GO:0010875~positive regulation of cholesterol efflux	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	LIF; IFNA1; IFNA2; IFNA8;	GO:0033141~positive regulation of peptidyl-serine phosphorylation of STAT protein	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	AGT; APOE; DRD1; EDNRB;	GO:0042311~vasodilation	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	ADRA1B; ANK2; HCN4; SCN10A;	GO:0055117~regulation of cardiac muscle contraction	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	NPR1; NPPB; AGTR1; FOXC2;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
down	CXCL9; EHD2; MYOG; MYF6;	GO:1901741~positive regulation of myoblast fusion	4	19	21.0526315789474	0.0430338691899335	0.292041435141291	1	1	0.999999835438707	0.999999835438707	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0451782719705438	1	1	1	1	1	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0451782719705438	1	1	1	1	1	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0451782719705438	1	1	1	1	1	1
down	BMP4; ISL1; MESP1;	GO:0003139~secondary heart field specification	3	11	27.2727272727273	0.0453190624545854	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	OPRK1; SCN10A; PENK;	GO:0007600~sensory perception	3	11	27.2727272727273	0.0453190624545854	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; ATOH8; TMEM100;	GO:0045603~positive regulation of endothelial cell differentiation	3	11	27.2727272727273	0.0453190624545854	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	BDNF; GRIK2; NPAS4;	GO:0060080~inhibitory postsynaptic potential	3	11	27.2727272727273	0.0453190624545854	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	SMAD6; GREM1; EMILIN1;	GO:0060394~negative regulation of pathway-restricted SMAD protein phosphorylation	3	11	27.2727272727273	0.0453190624545854	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	CACNA1H; ZP4; IQCF1;	GO:2000344~positive regulation of acrosome reaction	3	11	27.2727272727273	0.0453190624545854	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	FGF18; FGF1; FGF2; PDGFRB; FGFR1; MIF; DIRAS2; NOX4;	GO:0043406~positive regulation of MAP kinase activity	8	60	13.3333333333333	0.0454320450338085	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	CTSV; BCHE; TAT; CALCR; GHRHR; PAPPA; TPH2; TRIM63;	GO:0051384~response to glucocorticoid	8	60	13.3333333333333	0.0454320450338085	0.296322065625468	1	1	0.999999835438707	0.999999835438707	1
down	BMP4; TMEM119; PKDCC; OSR2; OSR1; NELL1;	GO:0030501~positive regulation of bone mineralization	6	39	15.3846153846154	0.0468504622842948	0.304291621553399	1	1	0.999999835438707	0.999999835438707	1
down	SEMA3E; COL4A1; GBX2; NFATC4; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	5	29	17.2413793103448	0.0469513387961414	0.304291621553399	1	1	0.999999835438707	0.999999835438707	1
down	FGF18; COL1A1; BMP4; TMEM119; SCX;	GO:0001958~endochondral ossification	5	29	17.2413793103448	0.0469513387961414	0.304291621553399	1	1	0.999999835438707	0.999999835438707	1
down	KERA; WFS1; EYA4; COL1A1; RBP4; RBP3; GNAT1; COL11A1; TYR; TIMP3; GLRB; LUM; LAMB2; NDP; EFEMP1; CNGA3; RIMS1; OPN4; LAMC3; CRYGN;	GO:0007601~visual perception	20	207	9.66183574879227	0.0469623916690369	0.304291621553399	1	1	0.999999835438707	0.999999835438707	1
down	SCT; BDNF; SCTR; NPAS4; FGF14; RIMS1; RIMS4;	GO:0048167~regulation of synaptic plasticity	7	50	14	0.0487177040650564	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	AGT; COL1A2; NPR1; NPPB; NPR2; EDNRB; GCGR; ACTA2;	GO:0008217~regulation of blood pressure	8	61	13.1147540983607	0.0488541802919688	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	MGP; COL11A1; ROR2; ALX1;	GO:0001502~cartilage condensation	4	20	20	0.0493187984125492	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	HOXC11; APELA; LAMC1; BMP4;	GO:0007492~endoderm development	4	20	20	0.0493187984125492	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	AGT; IGF1; ADRA1A; HAND2;	GO:0010613~positive regulation of cardiac muscle hypertrophy	4	20	20	0.0493187984125492	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	PLG; PLAT; FGG; HRG;	GO:0042730~fibrinolysis	4	20	20	0.0493187984125492	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	NGF; BDNF; NTF4; NDN;	GO:0048011~neurotrophin TRK receptor signaling pathway	4	20	20	0.0493187984125492	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	AGT; DRD2; GRM5; GRIK2;	GO:0048169~regulation of long-term neuronal synaptic plasticity	4	20	20	0.0493187984125492	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
down	COL4A1; NR2F2; LOX; CDH2;	GO:0048514~blood vessel morphogenesis	4	20	20	0.0493187984125492	0.314906114135791	1	1	0.999999835438707	0.999999835438707	1
